Merck & Co. stock holds near highs as dividend and analyst support underpin rally
Published on 09/14/2026 at 14:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Merck & Co. stock (ISIN US58933Y1055) is trading near its recent highs after a strong year-to-date performance of 38.76 percent, with the shares around USD 143.87 against an average Wall Street price target of USD 152.96 as of September 14, 2026.
Dividend date adds near-term catalyst
According to Moomoo on September 13, 2026, Merck & Co shareholders of record on September 15, 2026 will receive a cash dividend of USD 0.85 per share payable on October 7, 2026.
The same overview from Moomoo highlights that the ex-dividend date is September 15, 2026, meaning the stock typically trades without the right to the upcoming dividend from that date onward.
Analyst support and performance context
As 247 Wall St reported on September 14, 2026, Merck & Co shares have risen 8.28 percent over the last month and 38.76 percent year to date, outpacing many large pharma peers.
In the same analysis, 247 Wall St notes that Merck & Co’s average 12-month price target stands at USD 152.96, implying about 6 percent upside from a spot level of USD 143.87, with coverage consisting of 5 Strong Buy, 15 Buy and 8 Hold ratings.
Stock price and market data
On the New York Stock Exchange, Merck & Co stock recently traded around USD 143.87, with the prior close slightly lower and the one-month gain of 8.28 percent placing the shares close to their average analyst target as of mid-September 2026.
Merck & Co. stock at a glance
- Company: Merck & Co., Inc.
- ISIN: US58933Y1055
- Ticker: MRK
- Trading venue: NYSE
- Price (as of September 14, 2026): 143.87 USD
- Market capitalization: [value] USD (as of September 14, 2026)
- Sector / Industry: Health Care / Pharmaceuticals
- Index membership: S&P 500
- Next earnings date: [Month D, YYYY]
